Comment from Theresa Owhady

Summary: Theresa Owhady, a parent of a child with Neurofibromatosis Type 1, supports the Haystack Project’s petition to create a modernized regulatory framework for rare diseases. She argues that traditional drug development pathways are often unworkable for small, heterogeneous patient populations and calls for a framework that recognizes clinically meaningful endpoints and diverse study designs.